Evidence map›Paper›PMID 17912500›Full record

Trial reportPsychopharmacology2008

Effect of transdermal nicotine replacement on alcohol responses and alcohol self-administration.

Sherry A McKee, Stephanie S O'Malley, Julia Shi, Tricia Mase, Suchitra Krishnan-Sarin

Open access · greenAbstract readClinical Trial
In one paragraph

Trial report in Psychopharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 75 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. The Impact of Smoking Very Low Nicotine Content Cigarettes on Alcohol Use.Alcoholism, clinical and experimental research · 2016
    Trial
  6. Trial
  7. Dorsolateral prefrontal and orbitofrontal cortex interactions during self-control of cigarette craving.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Review
  16. Article
  17. Addiction-Related Outcomes of Nicotine and Alcohol Co-use: New Insights Following the Rise in Vaping.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sherry A McKeeDepartment of Psychiatry, Substance Abuse Center-CMHC, Yale University School of Medicine, 34 Park St, Suite S-211, New Haven, CT 06519, USA. sherry.mckee@yale.edu
Stephanie S O'Malley
Julia Shi
Tricia Mase
Suchitra Krishnan-Sarin
Yale University · US

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
ZIPRASIDONE IN TOURETTES SYNDROME, OBSESSIVE COMPULSIVE &PERVASIVE DEV. DISORDERM01RR000125 · NCRR · YALE UNIVERSITY · PI ALPERN, ROBERT J · 1985 to 2006
$24.1M
Tobacco Dependence &Risk Factors for Treatment FailureP50AA015632 · NIAAA · YALE UNIVERSITY · PI PICCIOTTO, MARINA R · 2004 to 2008
$9.2M
TOBACCO DEPENDENCE AND RISK FACTORS FOR TREATMENT FAILURP50DA013334 · NIDA · YALE UNIVERSITY · PI O'MALLEY, STEPHANIE S · 1999 to 2003
$8.0M
Improving Alcoholism TreatmentK05AA014715 · NIAAA · YALE UNIVERSITY · PI O'MALLEY, STEPHANIE S · 2004 to 2013
$2.1M
Smoking cessation treatments and alcohol drinkingR01AA015596 · NIAAA · YALE UNIVERSITY · PI MCKEE, SHERRY ANN · 2006 to 2009
$1.2M
Alcohol Self-Administration/Effect/Nicotine ReplacementR03AA013622 · NIAAA · YALE UNIVERSITY · PI MCKEE, SHERRY · 2002 to 2003
$137k
NCRR NIH HHS M01 RR000125NCRR NIH HHS UL1 RR024139NCRR NIH HHS UL1RR024139NIAAA NIH HHS K05 AA014715NIAAA NIH HHS K05AA014715NIAAA NIH HHS P50 AA015632NIAAA NIH HHS P50AA015632NIAAA NIH HHS R01 AA015596NIAAA NIH HHS R01AA015596NIAAA NIH HHS R03 AA013622NIAAA NIH HHS R03AA013622NIDA NIH HHS P50 DA013334NIDA NIH HHS P50DA13334
6 · The paper itself

Abstract

rationaleNicotine replacement is commonly used to treat tobacco use in heavy-drinking smokers. However, few studies have examined the effect of nicotine replacement on subjective and physiological responses to alcohol and alcohol drinking behavior.

objectiveThe primary aim of this within-subject, double-blind study was to examine whether transdermal nicotine replacement (0 mg vs 21 mg/day) altered response to a low-dose priming drink and subsequent ad libitum drinking behavior. MATERIALS AND

methodsSubjects (n=19) were non-treatment-seeking, non-dependent heavy drinkers who were daily smokers. Six hours after transdermal patch application, subjective and physiological responses to a priming drink [designed to raise blood alcohol levels (BALs) to 0.03 g/dl] were assessed. This was followed by a 2-h self-administration period where subjects could choose to consume up to eight additional drinks (each designed to raise BALs by 0.015 g/dl) or to receive monetary reinforcement for drinks not consumed.

resultsWe found that 6 h after patch application, tobacco craving associated with withdrawal relief was decreased, and systolic blood pressure and heart rate were increased in the active patch condition compared to the placebo patch condition. Subjective intoxication in response to the priming drink was attenuated in the active nicotine patch condition compared to 6 h of nicotine deprivation (i.e., placebo patch). During the self-administration period, subjects had longer latencies to start drinking and consequently appeared to consume fewer drinks when administered the active patch compared to the placebo patch.

conclusionsIn heavy drinkers, transdermal nicotine replacement compared to mild nicotine deprivation attenuated subjective and physiological alcohol responses and delayed the initiation of drinking.

Indexed as

Administration, CutaneousAdultAlcohol DrinkingBlood PressureChromatography, High Pressure LiquidDose-Response Relationship, DrugDouble-Blind MethodDrinking BehaviorFemaleHeart RateHumansMaleMiddle AgedMonitoring, PhysiologicNicotineOscillometryNicotine

Identifiers

PMID17912500
PMCPMC2862181
OpenAlexW2021147608

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.